ATM Regulates 3-Methylpurine-DNA Glycosylase and Promotes Therapeutic Resistance to Alkylating Agents-Reference-Cited by-同舟云学术

ATM Regulates 3-Methylpurine-DNA Glycosylase and Promotes Therapeutic Resistance to Alkylating Agents

Published:2014-08-06 Issue:10 Volume:4 Page:1198-1213
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discovery

Author:

Agnihotri Sameer,Burrell Kelly,Buczkowicz Pawel,Remke Marc,Golbourn Brian,Chornenkyy Yevgen,Gajadhar Aaron,Fernandez Nestor A.,Clarke Ian D.,Barszczyk Mark S.,Pajovic Sanja,Ternamian Christian,Head Renee,Sabha Nesrin,Sobol Robert W.,Taylor Michael D.,Rutka James T.,Jones Chris,Dirks Peter B.,Zadeh Gelareh,Hawkins Cynthia

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of DNA methylation-regulated WEE1 with potential implications in prognosis and immunotherapy for low-grade glioma;Cancer Biomarkers;2024-08-27

2. Oncometabolite 2-hydroxyglutarate suppresses basal protein levels of DNA polymerase beta that enhances alkylating agent and PARG inhibition induced cytotoxicity;DNA Repair;2024-08

3. Mammalian target of rapamycin inhibition protects glioma cells from temozolomide-induced cell death;Cell Death Discovery;2024-01-05

4. Randomly-shaped nanoplastics induced stronger biotoxicity targeted to earthworm Eisenia fetida species: Differential effects and the underlying mechanisms of realistic and commercial polystyrene nanoplastics;Science of The Total Environment;2023-06

5. Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma;Neuro-Oncology;2023-01-18